Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.521
+0.049 (10.40%)
At close: Nov 22, 2024, 4:00 PM
0.530
+0.009 (1.65%)
After-hours: Nov 22, 2024, 7:57 PM EST

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $13.11 million. The enterprise value is -$29.43 million.

Market Cap 13.11M
Enterprise Value -29.43M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

SNSE has 25.15 million shares outstanding. The number of shares has decreased by -14.70% in one year.

Current Share Class 25.15M
Shares Outstanding 25.15M
Shares Change (YoY) -14.70%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 2.10%
Owned by Institutions (%) 8.85%
Float 16.55M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.29
P/TBV Ratio 0.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.10.

Current Ratio 8.84
Quick Ratio 8.64
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -313.29

Financial Efficiency

Return on equity (ROE) is -51.04% and return on invested capital (ROIC) is -31.81%.

Return on Equity (ROE) -51.04%
Return on Assets (ROA) -30.19%
Return on Capital (ROIC) -31.81%
Revenue Per Employee n/a
Profits Per Employee -$1.06M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -21.02% in the last 52 weeks. The beta is 0.06, so SNSE's price volatility has been lower than the market average.

Beta (5Y) 0.06
52-Week Price Change -21.02%
50-Day Moving Average 0.52
200-Day Moving Average 0.78
Relative Strength Index (RSI) 50.65
Average Volume (20 Days) 397,340

Short Selling Information

The latest short interest is 194,685, so 0.77% of the outstanding shares have been sold short.

Short Interest 194,685
Short Previous Month 223,158
Short % of Shares Out 0.77%
Short % of Float 1.18%
Short Ratio (days to cover) 0.29

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -32.58M
Pretax Income -29.67M
Net Income -29.80M
EBITDA -31.26M
EBIT -32.58M
Earnings Per Share (EPS) -$1.19
Full Income Statement

Balance Sheet

The company has $47.00 million in cash and $4.47 million in debt, giving a net cash position of $42.53 million or $1.69 per share.

Cash & Cash Equivalents 47.00M
Total Debt 4.47M
Net Cash 42.53M
Net Cash Per Share $1.69
Equity (Book Value) 45.78M
Book Value Per Share 1.82
Working Capital 42.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.04 million and capital expenditures -$146,000, giving a free cash flow of -$25.19 million.

Operating Cash Flow -25.04M
Capital Expenditures -146,000
Free Cash Flow -25.19M
FCF Per Share -$1.00
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 14.70%
Shareholder Yield 14.70%
Earnings Yield -227.38%
FCF Yield -192.18%

Analyst Forecast

The average price target for SNSE is $4.33, which is 730.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.33
Price Target Difference 730.94%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 2.90%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1